Colorectal cancer risk in Crohn's disease

被引:72
作者
Freeman, Hugh James [1 ]
机构
[1] Univ British Columbia, Univ British Columbia Hosp, Dept Med Gastroenterol, Vancouver, BC V6T 1W5, Canada
关键词
colon cancer; Crohn's disease; surveillance; small bowel cancer;
D O I
10.3748/wjg.14.1810
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
There is recognized increased risk for colorectal cancer in patients with inflammatory bowel disease, particularly in long-standing and extensive ulcerative colitis. There also appears to be an increased rate of intestinal cancer in Crohn's disease, including both colon and small bowel sites. In Crohn's disease, evidence suggests that detection of colorectal cancer may be delayed with a worse prognosis. Some risk factors for cancer in Crohn's disease include the extent of inflammatory change within the colon and the presence of bypassed or excluded segments, including rectal "stump" cancer. In addition, the risk for other types of intestinal neoplasms may be increased in Crohn's disease, including lymphoma and carcinoid tumors. Earlier detection of colorectal cancer based on colonoscopy screening and surveillance may be achieved but, to date, this has not translated into a positive survival benefit. Moreover, newer staining methods and evolving micro-endoscopic techniques show promise, but have not significantly altered management. Future research should focus on development of molecular or other bio-markers that might predict future dysplasia or cancer development in Crohn's disease. (c) 2008 WJG. All rights reserved.
引用
收藏
页码:1810 / 1811
页数:2
相关论文
共 21 条
[1]  
Bernstein CN, 2001, CANCER-AM CANCER SOC, V91, P854, DOI 10.1002/1097-0142(20010215)91:4<854::AID-CNCR1073>3.0.CO
[2]  
2-Z
[3]   The relationship between infliximab treatment and lymphoma in Crohn's disease [J].
Bickston, SJ ;
Lichtenstein, GR ;
Arseneau, KO ;
Cohen, RB ;
Cominelli, F .
GASTROENTEROLOGY, 1999, 117 (06) :1433-1437
[4]   Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's disease [J].
Canavan, C ;
Abrams, KR ;
Mayberry, J .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 23 (08) :1097-1104
[5]   Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease [J].
Collins, P. D. ;
Mpofu, C. ;
Watson, A. J. ;
Rhodes, J. M. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2006, (02)
[6]  
Dossett LA, 2007, AM SURGEON, V73, P1181
[7]   Increased incidence of non-Hodgkin's lymphoma in inflammatory bowel disease patients on immunosuppressive therapy but overall risk is low [J].
Farrell, RJ ;
Ang, Y ;
Kileen, P ;
O'Briain, DS ;
Kelleher, D ;
Keeling, PWN ;
Weir, DG .
GUT, 2000, 47 (04) :514-519
[8]   Appendiceal carcinoids in Crohn's disease [J].
Freeman, HJ .
CANADIAN JOURNAL OF GASTROENTEROLOGY, 2003, 17 (01) :43-46
[9]   Tabulation of myeloid, lymphoid and intestinal malignancies in Crohn's disease [J].
Freeman, HJ .
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2002, 16 (11) :779-784
[10]   Colorectal cancer complicating Crohn's disease [J].
Freeman, HJ .
CANADIAN JOURNAL OF GASTROENTEROLOGY, 2001, 15 (04) :231-236